ES8608577A1 - Un metodo para inactivar virus que contienen lipidos esen- ciales en un vehiculo proteinico seco - Google Patents

Un metodo para inactivar virus que contienen lipidos esen- ciales en un vehiculo proteinico seco

Info

Publication number
ES8608577A1
ES8608577A1 ES543245A ES543245A ES8608577A1 ES 8608577 A1 ES8608577 A1 ES 8608577A1 ES 543245 A ES543245 A ES 543245A ES 543245 A ES543245 A ES 543245A ES 8608577 A1 ES8608577 A1 ES 8608577A1
Authority
ES
Spain
Prior art keywords
inactivate
utilizing
dissolved water
containing dissolved
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543245A
Other languages
English (en)
Other versions
ES543245A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES543245A0 publication Critical patent/ES543245A0/es
Publication of ES8608577A1 publication Critical patent/ES8608577A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

METODO PARA INACTIVAR VIRUS QUE CONTIENEN LIPIDOS ESENCIALES EN UN VEHICULO PROTEINICO SECO. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE PREPARA UNA COMPOSICION DE TRATAMIENTO FORMADA ESENCIALMENTE POR UN AGENTE DE TRATAMIENTO SELECCIONADO ENTRE HIDROCARBUROS HALOGENADOS Y ETERES, Y POR AGUA DISUELTA EN DICHO AGENTE DE TRATAMIENTO; SEGUNDA, SE PONE EN CONTACTO EL VIRUS DURANTE UN PERIODO CORTO DE TIEMPO Y A UNA TEMPERATURA DE TRATAMIENTO DE APROXIMADAMENTE 4 A 40 GRADOS, CON LA COMPOSICION DE TRATAMIENTO PREPARADA; Y POR ULTIMO, SE ELIMINA EL AGENTE DE TRATAMIENTO DEL VEHICULO PROTEINICO. DE APLICACION EN LOS VIRUS DE LA HEPATITIS B Y DE LA HEPATITIS NO-A, NO-B.
ES543245A 1984-05-18 1985-05-17 Un metodo para inactivar virus que contienen lipidos esen- ciales en un vehiculo proteinico seco Expired ES8608577A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/611,752 US4615886A (en) 1983-08-31 1984-05-18 Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus

Publications (2)

Publication Number Publication Date
ES543245A0 ES543245A0 (es) 1986-06-16
ES8608577A1 true ES8608577A1 (es) 1986-06-16

Family

ID=24450281

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543245A Expired ES8608577A1 (es) 1984-05-18 1985-05-17 Un metodo para inactivar virus que contienen lipidos esen- ciales en un vehiculo proteinico seco

Country Status (6)

Country Link
US (1) US4615886A (es)
EP (1) EP0182869A4 (es)
AU (1) AU592757B2 (es)
CA (1) CA1244348A (es)
ES (1) ES8608577A1 (es)
WO (1) WO1985005273A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
DE3900350A1 (de) * 1989-01-07 1990-07-12 Thomae Gmbh Dr K Verfahren zur herstellung virusfreier naturstoffe
WO1993017724A1 (en) * 1992-03-02 1993-09-16 Bioeng, Inc. Viral inactivation method
US5486293A (en) * 1994-03-21 1996-01-23 Hemasure, Inc. Removal of small exogenous molecules from biological fluids
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7439052B2 (en) 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US20030127386A1 (en) * 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US7033500B2 (en) * 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
JP2007527387A (ja) * 2003-07-03 2007-09-27 リピッド サイエンシーズ，インコーポレイテッド 脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
WO2019104237A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
EP3731814A4 (en) 2017-12-28 2021-09-29 HDL Therapeutics, Inc. METHOD OF PRESERVATION AND ADMINISTRATION OF HIGH DENSITY PRE-BETA LIPOPROTEIN EXTRACTED FROM HUMAN PLASMA

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847737A (en) * 1965-03-22 1974-11-12 A Kanarek Inactivation of myxoviruses and method of preparing a vaccine therefrom
US4020183A (en) * 1974-12-03 1977-04-26 Ortho Pharmaceutical Corporation Nonionic surface active anti-herpes simplex viral agents
US4113712A (en) * 1976-03-08 1978-09-12 The Green Cross Corporation HBsAG Particle composed of single polypeptide subunits and the preparation procedure
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
US4315919A (en) * 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions

Also Published As

Publication number Publication date
EP0182869A1 (en) 1986-06-04
ES543245A0 (es) 1986-06-16
CA1244348A (en) 1988-11-08
AU592757B2 (en) 1990-01-25
WO1985005273A1 (en) 1985-12-05
EP0182869A4 (en) 1987-01-20
US4615886A (en) 1986-10-07
AU4404585A (en) 1985-12-13

Similar Documents

Publication Publication Date Title
FI863581A0 (fi) Foerfarande foer samtidig rengoering och desinficering av kontaktlins.
ES2149768T3 (es) Conjugados de agentes enlazantes de celulas derivados de cc-1065.
DK566686A (da) Rensning og/eller desinfektion af kontaktlinser
ES2052909T3 (es) Purificacion de toxinas de la tos ferina.
IT1138543B (it) L'applicazione in terapeutica dei derivati del 4,5,6,7-tetraidroisossazolo(5,4-c)piridin-3-olo come miotonolitici
IT8019099A0 (it) Procedimento di sterilizzazione mediante l'uso di una soluzione di acqua ossigenata irradiata con radiazione ultravioletta
ZA9168B (en) Non oxidative ophthalmic compositions and methods for preserving and using same
ES2068862T3 (es) Derivado de 3'-hidroxibenzoxazinorifamicina; procedimiento para la preparacion del mismo y agente antibacteriano que contiene el mismo.
EP0633721A4 (en) DECONTAMINATION OF BLOOD COMPONENTS WITH 8-METHOXYPSORAL.
ES245234U (es) Perfeccionamientos en calzoncillos
AR231802A1 (es) Una solucion acuosa isotonica para limpiar,desinfectar y acopiar lentes de contacto hidrofilicas blandas,con exclusion de sus usos farmacologicos y terapeuticos
ES8503721A1 (es) "un metodo de inactivar un virus lipidico"
DK225579A (da) Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse
ES2135703T3 (es) Composicion y procedimiento destinados para prevenir y tratar las inflamaciones con la ayuda de inmunoglobulina.
ES549068A0 (es) Procedimiento de desinfeccion de lentes de contacto
ES2029297T3 (es) Empleo de una composicion para el tratamiento de las superficies de los suelos.
ES2179103T3 (es) Composicion detergente.
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
SE8504976L (sv) Ogondroppar innehallande bromocriptin
SE7702272L (sv) Forfarande for framstellning av bensotiazoler
ES2125361T3 (es) Uso de 5-amino-ftaloilhidrazida como agente anti-hipoxico y de defensa.
CO5580795A2 (es) Composicion para cateter y usos de las mismas
ES8608696A1 (es) Procedimiento de neutralizar h2o2 absorbido en lentes de contacto.
KR920014474A (ko) 담석 붕괴용 제제
NO153966C (no) Trihalogenallylderivater med sopphindrende og konserverende virkning samt midler som inneholder nevnte forbindelser.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401